Results 91 to 100 of about 756,852 (217)
Response of patients with refractory myasthenia gravis to rituximab: a retrospective study
Therapeutic Advances in Neurological Disorders, 2011 Introduction: Myasthenia gravis, an autoimmune disorder of neuromuscular transmission, is treated by an array of immunomodulating therapies. A variable response is observed with certain patients being medically refractory.
Richard J. Nowak +3 more
doaj +1 more source
Nursing Open, Volume 13, Issue 10, October 2026.ABSTRACT Aim To evaluate the impact of a 12‐element nurse‐led tracheostomy care bundle, compared with routine care, on stoma integrity, respiratory distress, and pneumonia‐related outcomes among patients with tracheostomies. Design A quasi‐experimental study was conducted among 80 critically ill patients with tracheostomies admitted to Mansoura ...
Eman Yasser Hammouda +4 more
wiley +1 more source
Diplopia and ptosis are among the most common symptoms of myasthenia gravis, with a variety of physiological reasons underpinning the susceptibility of the extraocular muscles.
Benatar, Michael, Wong, Sui Hsien
core +1 more source
INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol
BJU International, Volume 138, Issue 4, Page 607-619, October 2026.Background High‐risk non‐muscle‐invasive bladder cancer (HRNMIBC) has a variable prognosis, managed predominantly by local surgical resection and intravesical Bacillus Calmette–Guérin (BCG), or radical cystectomy (RC). Current treatments are poorly tolerated, have supply limitations and often fail to control the disease.
Ruby Lister‐Whelan +13 more
wiley +1 more source
Pharmacotherapy of Myasthenia Gravis
, 2015 The pharmacotherapy of Myasthenia Gravis is gradually advancing with special regard to immunospuression.
Omar, Majeed
core
A Pilot Study on Tocilizumab in Very-Late-Onset Myasthenia Gravis
, 2023 Ting-Ting Yang,1,* Ze-Yi Wang,1,* Ze-Xin Fan,1 Bo-Yi Yuan,1 Lin Ma,1 Jian-Feng Lu,1 Pen-Ju Liu,1 Yang He,2 Guang-Zhi Liu1 1Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People’s Republic of China ...
Yang TT +8 more
core
Miasthenia gravis in pediatric age
Acta Médica del Centro, 2008 Background: Myasthenia gravis is an autoimmune disorder characterized by fluctuating muscle weakness and fatigue of different muscle groups, secondary to a synaptic transmission alteration caused by the blockade and destruction of the acetylcholine ...
Liubka María Pérez Mederos +3 more
doaj
Frontalis sling procedure for ocular myasthenia gravis
, 2012 Shinichi Asamura1, Hirohiko Kakizaki2, Mitsuhiro Enjyo1, Takahiro Hashimoto1, Noritaka Isogai11Department of Plastic and Reconstructive Surgery, Kinki University School of Medicine, Osakasayama, Osaka, Japan; 2Department of Ophthalmology, Aichi Medical ...
Hashimoto T +4 more
core
An Atypical Case of Myasthenia Gravis: Purely Bulbar in a Young Male
McGill Journal of Medicine, 2020 Myasthenia Gravis (MG), an uncommon autoimmune syndrome caused by the failure of neuromuscular transmission, results from bind- ing of autoantibodies to proteins that are involved in signaling at the neuromuscular junction (1).
Muhammad Amer Saleem +3 more
doaj